The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of BPM31510-IV plus gemcitabine in advanced pancreatic ductal adenocarcinomas (PDAC).
 
Madappa N. Kundranda
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Bayer Health; Bayer Health; Bayer Health; Bayer Health
Research Funding - Celgene; Celgene; Celgene; Celgene
 
David Propper
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
Speakers' Bureau - Merck; Merck; Merck; Merck
Travel, Accommodations, Expenses - Celgene; Celgene; Celgene; Celgene; Celgene; Celgene; Celgene; Celgene
 
Paul S. Ritch
No Relationships to Disclose
 
James Strauss
No Relationships to Disclose
 
Manuel Hidalgo
Stock and Other Ownership Interests - Agenus; Agenus; Agenus; Agenus; BioOncotech; BioOncotech; BioOncotech; BioOncotech; Champions Oncology; Champions Oncology; Champions Oncology; Champions Oncology; Nelum Corp.; Nelum Corp.; Nelum Corp.; Nelum Corp.; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech
Honoraria - Agenus; Agenus; Agenus; Agenus; InxMed; InxMed; InxMed; InxMed; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Takeda; Takeda; Takeda; Takeda
Consulting or Advisory Role - Agenus; Agenus; Agenus; Agenus; Bayer; Bayer; Bayer; Bayer; Oncomatrix; Oncomatrix; Oncomatrix; Oncomatrix; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Takeda; Takeda; Takeda; Takeda
Research Funding - BiolineRx; BiolineRx; BiolineRx; BiolineRx; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma
Patents, Royalties, Other Intellectual Property - Royalties from Myriad for PALB2 patent; Royalties from Myriad for PALB2 patent; Royalties from Myriad for PALB2 patent; Royalties from Myriad for PALB2 patent
Expert Testimony - Myriad Genetics; Myriad Genetics; Myriad Genetics; Myriad Genetics
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; BiolineRx; BiolineRx; BiolineRx; BiolineRx; Celgene; Celgene; Celgene; Celgene; Menarini; Menarini; Menarini; Menarini
 
Roopinder Gillmore
No Relationships to Disclose
 
Rangaprasad Sarangarajan
Employment - BERG; BERG; BERG; BERG
Leadership - BERG; BERG; BERG; BERG
Stock and Other Ownership Interests - BERG; BERG; BERG; BERG
Research Funding - BERG; BERG; BERG; BERG
Patents, Royalties, Other Intellectual Property - I am recipient of patent; I am recipient of patent; I am recipient of patent; I am recipient of patent
Travel, Accommodations, Expenses - BERG; BERG; BERG; BERG
 
Niven R. Narain
Employment - Berg; Berg; Berg; Berg
Leadership - Berg; Berg; Berg; Berg
Stock and Other Ownership Interests - Berg; Berg; Berg; Berg
Research Funding - Berg; Berg; Berg; Berg
Patents, Royalties, Other Intellectual Property - Berg Pharma; Berg Pharma; Berg Pharma; Berg Pharma
 
Michael A. Kiebish
Employment - Berg Pharma; Berg Pharma; Berg Pharma; Berg Pharma
Leadership - Berg Pharma; Berg Pharma; Berg Pharma; Berg Pharma
Stock and Other Ownership Interests - Berg Pharma; Berg Pharma; Berg Pharma; Berg Pharma
Patents, Royalties, Other Intellectual Property - Provisional and granted patents; Provisional and granted patents; Provisional and granted patents; Provisional and granted patents
Travel, Accommodations, Expenses - Berg Pharma; Berg Pharma; Berg Pharma; Berg Pharma
 
Leonardo O Rodrigues
No Relationships to Disclose
 
Elder Granger
Employment - The 5Ps; The 5Ps; The 5Ps; The 5Ps; The 5Ps (I); The 5Ps (I); The 5Ps (I); The 5Ps (I)
Leadership - Berg Pharma; Berg Pharma; Berg Pharma; Berg Pharma; Cigna; Cigna; Cigna; Cigna; CTIS; CTIS; CTIS; CTIS; Defense Logistics Health; Defense Logistics Health; Defense Logistics Health; Defense Logistics Health
Stock and Other Ownership Interests - Cigna; Cigna; Cigna; Cigna; Defense Logistics Health; Defense Logistics Health; Defense Logistics Health; Defense Logistics Health; Express Scripts; Express Scripts; Express Scripts; Express Scripts
Travel, Accommodations, Expenses - Berg; Berg; Berg; Berg; Cigna; Cigna; Cigna; Cigna; CTIS; CTIS; CTIS; CTIS; Defense Logistics Health; Defense Logistics Health; Defense Logistics Health; Defense Logistics Health
 
Ramesh Ramanathan
Employment - Merck; Merck; Merck; Merck
 
Angela Tatiana Alistar
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck; Merck; Merck; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; celgene; celgene; celgene; celgene; Rafa Pharmaceutical; Rafa Pharmaceutical; Rafa Pharmaceutical; Rafa Pharmaceutical
 
Lynne A. Bui
Employment - Global Cancer Research Institute; Global Cancer Research Institute; Global Cancer Research Institute; Global Cancer Research Institute; Khloris Biosciences; Khloris Biosciences; Khloris Biosciences; Khloris Biosciences
Leadership - Global Cancer Research Institute; Global Cancer Research Institute; Global Cancer Research Institute; Global Cancer Research Institute; Khloris Biosciences; Khloris Biosciences; Khloris Biosciences; Khloris Biosciences
Stock and Other Ownership Interests - Global Cancer Research Institute; Global Cancer Research Institute; Global Cancer Research Institute; Global Cancer Research Institute; Khloris Biosciences; Khloris Biosciences; Khloris Biosciences; Khloris Biosciences
Research Funding - Global Cancer Research Institute; Global Cancer Research Institute; Global Cancer Research Institute; Global Cancer Research Institute; Khloris Biosciences; Khloris Biosciences; Khloris Biosciences; Khloris Biosciences
Patents, Royalties, Other Intellectual Property - Khloris Biosciences; Khloris Biosciences; Khloris Biosciences; Khloris Biosciences
 
Sant P. Chawla
Honoraria - Amgen; Amgen; Amgen; Amgen; CytRx Corporation; CytRx Corporation; CytRx Corporation; CytRx Corporation; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Ignyta; Ignyta; Ignyta; Ignyta; Immune Design; Immune Design; Immune Design; Immune Design; Janssen; Janssen; Janssen; Janssen; Karyopharm Therapeutics; Karyopharm Therapeutics; Karyopharm Therapeutics; Karyopharm Therapeutics; Roche; Roche; Roche; Roche; SARC: Sarcoma Alliance for Research though Collaboration; SARC: Sarcoma Alliance for Research though Collaboration; SARC: Sarcoma Alliance for Research though Collaboration; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; Threshold Pharmaceuticals; Threshold Pharmaceuticals; Threshold Pharmaceuticals; TRACON Pharma; TRACON Pharma; TRACON Pharma; TRACON Pharma
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; CytRx Corporation; CytRx Corporation; CytRx Corporation; CytRx Corporation; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Ignyta; Ignyta; Ignyta; Ignyta; Immune Design; Immune Design; Immune Design; Immune Design; Janssen; Janssen; Janssen; Janssen; Karyopharm Therapeutics; Karyopharm Therapeutics; Karyopharm Therapeutics; Karyopharm Therapeutics; Roche; Roche; Roche; Roche; SARC: Sarcoma Alliance for Research though Collaboration; SARC: Sarcoma Alliance for Research though Collaboration; SARC: Sarcoma Alliance for Research though Collaboration; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; Threshold Pharmaceuticals; Threshold Pharmaceuticals; Threshold Pharmaceuticals; TRACON Pharma; TRACON Pharma; TRACON Pharma; TRACON Pharma
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; CytRx Corporation; CytRx Corporation; CytRx Corporation; CytRx Corporation; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Ignyta; Ignyta; Ignyta; Ignyta; Immune Design; Immune Design; Immune Design; Immune Design; Janssen; Janssen; Janssen; Janssen; Karyopharm Therapeutics; Karyopharm Therapeutics; Karyopharm Therapeutics; Karyopharm Therapeutics; Roche; Roche; Roche; Roche; SARC: Sarcoma Alliance for Research though Collaboration; SARC: Sarcoma Alliance for Research though Collaboration; SARC: Sarcoma Alliance for Research though Collaboration; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; Threshold Pharmaceuticals; Threshold Pharmaceuticals; Threshold Pharmaceuticals; TRACON Pharma; TRACON Pharma; TRACON Pharma; TRACON Pharma
Research Funding - Amgen; Amgen; Amgen; Amgen; CytRx Corporation; CytRx Corporation; CytRx Corporation; CytRx Corporation; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Ignyta; Ignyta; Ignyta; Ignyta; Immune Design; Immune Design; Immune Design; Immune Design; Janssen; Janssen; Janssen; Janssen; Janssen; Janssen; Janssen; Janssen; Karyopharm Therapeutics; Karyopharm Therapeutics; Karyopharm Therapeutics; Karyopharm Therapeutics; Roche; Roche; Roche; Roche; SARC: Sarcoma Alliance for Research though Collaboration; SARC: Sarcoma Alliance for Research though Collaboration; SARC: Sarcoma Alliance for Research though Collaboration; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; Threshold Pharmaceuticals; Threshold Pharmaceuticals; Threshold Pharmaceuticals; TRACON Pharma; TRACON Pharma; TRACON Pharma; TRACON Pharma
 
Anna A. Niewiarowska
Research Funding - Berg (Inst); Berg (Inst); Berg (Inst); Berg (Inst); Berg (Inst); Berg (Inst); Berg (Inst); Berg (Inst)